Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 36-42

  Aune, Erlend ^a   Endresen, Knut ^b   Fox, Keith A A ^c   Steen Hansen, Jon Erik ^a   Roislien, Jo ^a,d   Hjelmesaeth, Joran ^a   Otterstad, Jan Erik ^a  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION; STROKE;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72049128583     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.641     Document Type: Article

References (27)

1. Aune E., Hjelmesaeth J., Fox K.A., Endresen K., and Otterstad J.E. High mortality rates in conservatively managed patients with acute coronary syndrome. Scand Cardiovasc J 40 (2006) 137-144
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Fox K.A., Poole-Wilson P.A., Henderson R.A., Clayton T.C., Chamberlain D.A., Shaw T.R., Wheatley D.J., and Pocock S.J. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360 (2002) 743-751
4. Mehta S.R., Cannon C.P., Fox K.A., Wallentin L., Boden W.E., Spacek R., Widimsky P., McCullough P.A., Hunt D., Braunwald E., and Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
5. O'Donoghue M., Boden W.E., Braunwald E., Cannon C.P., Clayton T.C., de Winter R.J., Fox K.A., Lagerqvist B., McCullough P.A., Murphy S.A., Spacek R., Swahn E., Wallentin L., Windhausen F., and Sabatine M.S. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 300 (2008) 71-80
6. Fox K.A., Steg P.G., Eagle K.A., Goodman S.G., Anderson Jr. F.A., Granger C.B., Flather M.D., Budaj A., Quill A., and Gore J.M. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 297 (2007) 1892-1900
7. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., Jorgensen E., Marco J., Nordrehaug J.E., Ruzyllo W., Urban P., Stone G.W., and Wijns W. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
8. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
9. Fox K.A., Dabbous O.H., Goldberg R.J., Pieper K.S., Eagle K.A., Van de Werf F., Avezum A., Goodman S.G., Flather M.D., Anderson Jr. F.A., and Granger C.B. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333 (2006) 1091-1094
10. Vestfold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 10 (2003) 429-437
11. Bertrand M.E., Simoons M.L., Fox K.A., Wallentin L.C., Hamm C.W., McFadden E., De Feyter P.J., Specchia G., and Ruzyllo W. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
12. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., Pepine C.J., Schaeffer J.W., Smith III E.E., Steward D.E., Theroux P., Gibbons R.J., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Hiratzka L.F., Jacobs A.K., and Smith Jr. S.C. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
13. Boersma E. Does time matter?. A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 (2006) 779-788
14. Andersen H.R., Nielsen T.T., Rasmussen K., Thuesen L., Kelbaek H., Thayssen P., Abildgaard U., Pedersen F., Madsen J.K., Grande P., Villadsen A.B., Krusell L.R., Haghfelt T., Lomholt P., Husted S.E., Vigholt E., Kjaergard H.K., and Mortensen L.S. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
15. Widimsky P., Budesinsky T., Vorac D., Groch L., Zelizko M., Aschermann M., Branny M., St'asek J., and Formanek P. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24 (2003) 94-104
16. Mehta S.R., Granger C.B., Boden W.E., Steg P.G., Bassand J.P., Faxon D.P., Afzal R., Chrolavicius S., Jolly S.S., Widimsky P., Avezum A., Rupprecht H.J., Zhu J., Col J., Natarajan M.K., Horsman C., Fox K.A., and Yusuf S. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360 (2009) 2165-2175
17. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., Swahn E., and FRISC II Investigators. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356 (2000) 9-16
18. de Winter R.J., Windhausen F., Cornel J.H., Dunselman P.H., Janus C.L., Bendermacher P.E., Michels H.R., Sanders G.T., Tijssen J.G., and Verheugt F.W. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
19. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., and Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
20. Terkelsen C.J., Lassen J.F., Norgaard B.L., Gerdes J.C., Jensen T., Gotzsche L.B., Nielsen T.T., and Andersen H.R. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 26 (2005) 18-26
21. Wilhelmsson C., Vedin J.A., Elmfeldt D., Tibblin G., and Wilhelmsen L. Smoking and myocardial infarction. Lancet 1 (1975) 415-420
22. Cavender J.B., Rogers W.J., Fisher L.D., Gersh B.J., Coggin C.J., Myers W.O., and CASS Investigators. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. J Am Coll Cardiol 20 (1992) 287-294
23. Barone-Adesi F., Vizzini L., Merletti F., and Richiardi L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 27 (2006) 2468-2472
24. Centers for Disease Control and Prevention. Reduced hospitalizations for acute myocardial infarction after implementation of a smoke-free ordinance-City of Pueblo, Colorado, 2002-2006. MMWR Morb Mortal Wkly Rep 57 (2009) 1373-1377
25. Pell J.P., Haw S., Cobbe S., Newby D.E., Pell A.C., Fischbacher C., McConnachie A., Pringle S., Murdoch D., Dunn F., Oldroyd K., Macintyre P., O'Rourke B., and Borland W. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 359 (2008) 482-491
26. Statistics Norway 2009. www.ssb.no/english/subjects/03/01/10/dodsarsak_en/ Accessed September 12, 2008
27. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502